Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation is one of the more common side effects of Mounjaro (tirzepatide), reported by a meaningful proportion of people starting or increasing their dose. Mounjaro slows how quickly food moves through the gut — a feature that reduces appetite but can also leave digestion sluggish, especially in the first few weeks of treatment. It is a prescription-only medicine, and any concerns about constipation on Mounjaro are worth raising with your prescribing clinician, who can advise based on your full picture. Most people find it manageable; the steps below explain what is happening and what tends to help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, which together reduce appetite and slow gastric emptying. That slowing is precisely why people feel fuller for longer, but the same mechanism applies further along the digestive tract, meaning the whole system runs at a gentler pace. Stools spend longer in the large intestine, where water is drawn out of them, and the result is harder, less frequent bowel movements that are a recognised consequence of how the medicine works.
This is not a sign the medicine is not working, nor that something has gone wrong. The NHS's patient information for tirzepatide lists constipation among the common side effects, meaning it is estimated to affect at least one in ten people on the medicine. Knowing that does not make it comfortable, but it does mean it is expected and, in most cases, temporary.
The effect is often sharpest when you first start and again at each dose increase. Your gut is recalibrating. For the majority of people, things settle within a couple of weeks once the body adjusts to each new dose level. If you want to read more about whether Mounjaro causes constipation and why it happens at a physiological level, our detailed explainer covers the mechanism more fully.
Hydration is the single most effective lever most people can pull. Mounjaro reduces thirst as well as appetite, many people simply forget to drink enough. Aim for steady fluid intake across the day rather than catching up in the evening. One easy anchor: before the kettle goes on in the morning, have a glass of water first. It sounds small. It adds up.
Dietary fibre matters too, but the right kind. Soluble fibre (oats, lentils, cooked vegetables, fruit) softens stools and feeds the gut. Insoluble fibre in large quantities can occasionally worsen bloating when motility is already slow, so a gradual increase is smarter than a sudden overhaul. Because Mounjaro reduces how much you eat overall, protein adequacy becomes important: aim for protein-rich foods at most meals so that your reduced food intake still meets your body's needs.
Movement helps. Even a short walk after eating stimulates the gut. Light resistance exercise has a similar effect. These are things most people already know, the difference is that on Mounjaro, your appetite signals are quieter, so the nudge to move needs to be deliberate rather than driven by eating a large meal.
For more specific tactics, our prescribers have helped compile practical tips for managing constipation on Mounjaro that go into further detail on fibre choices and timing.
Most constipation on Mounjaro does not need medical intervention beyond lifestyle adjustments. But there are situations where a conversation with a clinician is the right next step.
If constipation is severe (meaning no bowel movement for more than three or four days despite dietary changes) a pharmacist can advise on short-term laxatives that are compatible with tirzepatide. An osmotic laxative (such as lactulose or macrogol) is typically preferable to stimulant types for ongoing use, but this is a conversation to have with your own pharmacist or prescriber rather than a self-prescribing decision.
If you are also experiencing stomach cramps that are getting worse rather than better, contact your prescribing clinician. They may want to consider whether your current dose is appropriate, or whether a slower titration would suit you better. Our guide on how to stop constipation on Mounjaro covers practical steps you can discuss with your prescriber, including advice on dose adjustments and titration. Details about dose escalation are explained in the Mounjaro patient information leaflet; the electronic Medicines Compendium (eMC) holds the full Summary of Product Characteristics if you want the clinical-level detail.
You can find a broader overview of what to expect across all the common side effects on our Mounjaro side effects page.
Constipation itself is rarely an emergency. But two scenarios on Mounjaro need prompt attention, and it is important not to confuse them with ordinary digestive slowness.
First: severe, persistent stomach pain that spreads towards the back, especially if accompanied by vomiting. This pattern can indicate pancreatitis, an infrequent but serious side effect of GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a risk to be aware of; the guidance is clear that severe radiating stomach pain should not be managed at home. Call 111 or attend A&E if this describes your symptoms.
Second: signs of dehydration from prolonged or severe vomiting and diarrhoea alongside constipation (diarrhoea and constipation can alternate in some people) (dizziness, reduced urination, extreme thirst) also warrant medical assessment, as GLP-1-related dehydration can affect kidney function.
Our page on Mounjaro's serious side effects covers both of these in more detail, including exactly what to watch for and who to contact. And as a reminder: you can report any side effect, however mild, through the MHRA's Yellow Card scheme, the data helps regulators monitor real-world safety.
If you have questions about starting Mounjaro or would like side effects and suitability discussed as part of a full clinical review, our prescribers cover all of this during the consultation process. Start your free consultation and a GPhC-registered prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.